Search research articles
Contact Us
Filters
Showing results (41-50 of 359) with videos related to
Page
of 36
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 1, 1985
Growth-related variations in the glycosaminoglycan synthesis of ultraviolet light-induced murine cutaneous fibrosarcoma cells
M Piepkorn, H Carney, A Linker
Biochemical and Biophysical Research Communications
|
September 30, 1991
Proteoglycan and glycosaminoglycan free chain expression in keratinocytes, endothelium, and mesenchymal cells
M Piepkorn, P Hovingh, A Linker
Experimental & Translational Stroke Medicine
|
February 10, 2010
Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
Ralf A Linker, De-Hyung Lee
Der Nervenarzt
|
September 23, 2008
[Choice of early and escalation treatment options for multiple sclerosis]
R A Linker, B C Kieseier
Journal of Community Health Nursing
|
June 21, 2002
Compliance of licensed child care centers with the American Academy of Pediatrics' recommendations for infant sleep positions
Kathleen M Ford, Lynda A Linker
The Biochemical Journal
|
July 15, 1986
Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates
P Hovingh, M Piepkorn, A Linker
Bone Marrow Transplantation
|
September 1, 1995
Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin
D F Roychowdhury, C A Linker
European Journal of Biochemistry
|
February 1, 1993
Differentially expressed patterns of glycosaminoglycan structure in heparan sulfate proteoglycans and free chains
P Hovingh, M Piepkorn, A Linker
The Journal of Investigative Dermatology
|
October 1, 1992
Topography of proteoglycan and glycosaminoglycan free chain expression in 3T3 fibroblasts and human keratinocytes
M Piepkorn, P Hovingh, A Linker
Therapeutic Advances in Neurological Disorders
|
December 25, 2010
Innovative monoclonal antibody therapies in multiple sclerosis
Ralf A Linker, Bernd C Kieseier
Page
of 36
Search research articles
Search
Showing results (41-50 of 359) with videos related to
Sort By:
Page
of 36
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 1, 1985
Growth-related variations in the glycosaminoglycan synthesis of ultraviolet light-induced murine cutaneous fibrosarcoma cells
M Piepkorn, H Carney, A Linker
Biochemical and Biophysical Research Communications
|
September 30, 1991
Proteoglycan and glycosaminoglycan free chain expression in keratinocytes, endothelium, and mesenchymal cells
M Piepkorn, P Hovingh, A Linker
Experimental & Translational Stroke Medicine
|
February 10, 2010
Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
Ralf A Linker, De-Hyung Lee
Der Nervenarzt
|
September 23, 2008
[Choice of early and escalation treatment options for multiple sclerosis]
R A Linker, B C Kieseier
Journal of Community Health Nursing
|
June 21, 2002
Compliance of licensed child care centers with the American Academy of Pediatrics' recommendations for infant sleep positions
Kathleen M Ford, Lynda A Linker
The Biochemical Journal
|
July 15, 1986
Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates
P Hovingh, M Piepkorn, A Linker
Bone Marrow Transplantation
|
September 1, 1995
Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin
D F Roychowdhury, C A Linker
European Journal of Biochemistry
|
February 1, 1993
Differentially expressed patterns of glycosaminoglycan structure in heparan sulfate proteoglycans and free chains
P Hovingh, M Piepkorn, A Linker
The Journal of Investigative Dermatology
|
October 1, 1992
Topography of proteoglycan and glycosaminoglycan free chain expression in 3T3 fibroblasts and human keratinocytes
M Piepkorn, P Hovingh, A Linker
Therapeutic Advances in Neurological Disorders
|
December 25, 2010
Innovative monoclonal antibody therapies in multiple sclerosis
Ralf A Linker, Bernd C Kieseier
Page
of 36